HUP0103806A2 - Szerin-proteáz inhibitorok és ezeket tartalmazó gyógyászati készítmények - Google Patents
Szerin-proteáz inhibitorok és ezeket tartalmazó gyógyászati készítményekInfo
- Publication number
- HUP0103806A2 HUP0103806A2 HU0103806A HUP0103806A HUP0103806A2 HU P0103806 A2 HUP0103806 A2 HU P0103806A2 HU 0103806 A HU0103806 A HU 0103806A HU P0103806 A HUP0103806 A HU P0103806A HU P0103806 A2 HUP0103806 A2 HU P0103806A2
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- protease inhibitor
- serine protease
- serine
- Prior art date
Links
- 229940122055 Serine protease inhibitor Drugs 0.000 title 1
- 101710102218 Serine protease inhibitor Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000003001 serine protease inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98203559 | 1998-10-23 | ||
| PCT/EP1999/007928 WO2000024718A1 (en) | 1998-10-23 | 1999-10-19 | Serine protease inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0103806A2 true HUP0103806A2 (hu) | 2002-02-28 |
| HUP0103806A3 HUP0103806A3 (en) | 2002-03-28 |
Family
ID=8234249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0103806A HUP0103806A3 (en) | 1998-10-23 | 1999-10-19 | Serine protease inhibitor and pharmaceutical compositions containing them |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6903107B1 (hu) |
| EP (1) | EP1123280A1 (hu) |
| JP (1) | JP2002528438A (hu) |
| KR (1) | KR20010075648A (hu) |
| CN (1) | CN1146543C (hu) |
| AR (1) | AR020922A1 (hu) |
| AU (1) | AU763667B2 (hu) |
| BR (1) | BR9914694A (hu) |
| CA (1) | CA2346990A1 (hu) |
| CO (1) | CO5140114A1 (hu) |
| CZ (1) | CZ20011440A3 (hu) |
| HU (1) | HUP0103806A3 (hu) |
| ID (1) | ID29885A (hu) |
| IL (1) | IL142398A0 (hu) |
| NO (1) | NO20011966L (hu) |
| NZ (1) | NZ511067A (hu) |
| PE (1) | PE20001283A1 (hu) |
| PL (1) | PL347948A1 (hu) |
| RU (1) | RU2232760C2 (hu) |
| SK (1) | SK5372001A3 (hu) |
| TR (1) | TR200101120T2 (hu) |
| TW (1) | TW575567B (hu) |
| WO (1) | WO2000024718A1 (hu) |
| ZA (1) | ZA200102970B (hu) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10046272A1 (de) * | 2000-09-19 | 2002-03-28 | Merck Patent Gmbh | Aminoheterocyclen (Faktor Xa Inhibitoren 14) |
| US6924285B2 (en) | 2002-03-30 | 2005-08-02 | Boehringer Ingelheim Pharma Gmbh & Co. | Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
| US7479502B2 (en) | 2002-12-03 | 2009-01-20 | Pharmacyclics, Inc. | 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors |
| GB0309850D0 (en) | 2003-04-30 | 2003-06-04 | Astrazeneca Ab | Quinazoline derivatives |
| GB0322409D0 (en) | 2003-09-25 | 2003-10-29 | Astrazeneca Ab | Quinazoline derivatives |
| GB0326459D0 (en) | 2003-11-13 | 2003-12-17 | Astrazeneca Ab | Quinazoline derivatives |
| CN1914182B (zh) | 2004-02-03 | 2011-09-07 | 阿斯利康(瑞典)有限公司 | 喹唑啉衍生物 |
| PT1899322E (pt) | 2005-06-28 | 2009-11-09 | Sanofi Aventis | Derivados de isoquinolina como inibidores de rho-cinase |
| ATE521595T1 (de) | 2005-07-26 | 2011-09-15 | Sanofi Sa | Cyclohexylaminisochinolonderivate als rho-kinase- inhibitor |
| NI200800025A (es) * | 2005-07-26 | 2009-03-03 | Derivados de isoquinolona sustituidos con piperidinilo en calidad de inhibidores de rho-quinasa | |
| TWI389899B (zh) | 2006-08-08 | 2013-03-21 | Msd Oss Bv | 具口服活性之凝血酶抑制劑 |
| EP1921070A1 (de) | 2006-11-10 | 2008-05-14 | Boehringer Ingelheim Pharma GmbH & Co. KG | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung |
| AU2007338409B2 (en) * | 2006-12-27 | 2012-12-13 | Sanofi-Aventis | Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives |
| CN101573354B (zh) * | 2006-12-27 | 2014-02-12 | 塞诺菲-安万特股份有限公司 | 取代的异喹啉类及其作为Rho-激酶抑制剂的用途 |
| CA2673920C (en) | 2006-12-27 | 2015-03-24 | Sanofi-Aventis | Cycloalkylamine substituted isoquinoline derivatives |
| AU2007338408B2 (en) * | 2006-12-27 | 2012-07-26 | Sanofi-Aventis | Substituted isoquinoline and isoquinolinone derivatives |
| MX2009005825A (es) | 2006-12-27 | 2009-06-16 | Sanofi Aventis | Derivados de isoquinolina e isoquinolinona sustituidos en calidad de inhibidores de rho-quinasa. |
| JP5405314B2 (ja) | 2006-12-27 | 2014-02-05 | サノフイ | シクロアルキルアミン置換イソキノロン誘導体 |
| SI2102164T1 (sl) | 2006-12-27 | 2011-03-31 | Sanofi Aventis | Izokinolinski in izokinolinonski derivati, substituirani s cikloalkilaminom |
| MX2009007610A (es) | 2007-02-06 | 2009-07-24 | Boehringer Ingelheim Int | Heterociclicos biciclicos, medicamentos que contienen estos compuestos, su utilizacion y procedimientos para su preparacion. |
| EP2245026B1 (de) | 2008-02-07 | 2012-08-01 | Boehringer Ingelheim International GmbH | Spirocyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
| MX2010012442A (es) | 2008-05-13 | 2011-10-11 | Astrazeneca Ab | Sal de fumarato de 4-(3-cloro-2-fluoroanilino)-7-metoxi-6-{[1-(n-m etilcarbamoilmetil) piperidin-4-il]oxi}quinazolina. |
| RU2538588C2 (ru) * | 2008-06-24 | 2015-01-10 | Санофи-Авентис | ЗАМЕЩЕННЫЕ ИЗИХИНОЛИНЫ И ИЗОХИНОЛИНОНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ Rho-КИНАЗЫ |
| MX2010013974A (es) * | 2008-06-24 | 2011-01-14 | Sanofi Aventis | Isoquinolinas e isoquinolinonas 6-sustituidas. |
| DK2303845T3 (da) * | 2008-06-24 | 2013-12-16 | Sanofi Sa | Bi- og polycyklisk substitueret isoquinolin og bi- og polycykliske substituerede isoquinolinderivater som rho-kinasehæmmere |
| JP5539351B2 (ja) | 2008-08-08 | 2014-07-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | シクロヘキシルオキシ置換ヘテロ環、これらの化合物を含有する医薬、およびそれらを生成するための方法 |
| JP2014523900A (ja) * | 2011-06-28 | 2014-09-18 | インヒブルクス リミティド ライアビリティ カンパニー | セルピン融合ポリペプチド及びその使用方法 |
| US10400029B2 (en) | 2011-06-28 | 2019-09-03 | Inhibrx, Lp | Serpin fusion polypeptides and methods of use thereof |
| AU2012275295B2 (en) * | 2011-06-28 | 2016-11-10 | Inhibrx, Lp | WAP domain fusion polypeptides and methods of use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4473501A (en) | 1981-05-04 | 1984-09-25 | G. D. Searle & Co. | Dihydro azino isoquinolines |
| GB8908229D0 (en) | 1989-04-12 | 1989-05-24 | Smithkline Beckman Intercredit | Compounds |
| CN1221407A (zh) | 1996-04-13 | 1999-06-30 | 英国阿斯特拉药品有限公司 | 氨基异喹啉和氨基噻吩并吡啶衍生物及其作为抗炎剂的用途 |
| IL123986A (en) * | 1997-04-24 | 2011-10-31 | Organon Nv | Medicinal compounds |
| EP1065200A4 (en) * | 1998-03-19 | 2003-01-02 | Ajinomoto Kk | Aminoisoquinoline DERIVATIVES |
-
1999
- 1999-10-04 TW TW88117079A patent/TW575567B/zh not_active IP Right Cessation
- 1999-10-19 TR TR2001/01120T patent/TR200101120T2/xx unknown
- 1999-10-19 CA CA002346990A patent/CA2346990A1/en not_active Abandoned
- 1999-10-19 BR BR9914694-0A patent/BR9914694A/pt not_active IP Right Cessation
- 1999-10-19 IL IL14239899A patent/IL142398A0/xx unknown
- 1999-10-19 HU HU0103806A patent/HUP0103806A3/hu unknown
- 1999-10-19 EP EP99950761A patent/EP1123280A1/en not_active Withdrawn
- 1999-10-19 CN CNB998124966A patent/CN1146543C/zh not_active Expired - Fee Related
- 1999-10-19 JP JP2000578288A patent/JP2002528438A/ja not_active Withdrawn
- 1999-10-19 RU RU2001113734/04A patent/RU2232760C2/ru not_active IP Right Cessation
- 1999-10-19 KR KR1020017004938A patent/KR20010075648A/ko not_active Application Discontinuation
- 1999-10-19 ID IDW20010914A patent/ID29885A/id unknown
- 1999-10-19 CZ CZ20011440A patent/CZ20011440A3/cs unknown
- 1999-10-19 US US09/830,227 patent/US6903107B1/en not_active Expired - Fee Related
- 1999-10-19 AU AU63413/99A patent/AU763667B2/en not_active Ceased
- 1999-10-19 SK SK537-2001A patent/SK5372001A3/sk unknown
- 1999-10-19 PL PL99347948A patent/PL347948A1/xx unknown
- 1999-10-19 WO PCT/EP1999/007928 patent/WO2000024718A1/en not_active Application Discontinuation
- 1999-10-19 NZ NZ511067A patent/NZ511067A/xx unknown
- 1999-10-21 PE PE1999001065A patent/PE20001283A1/es not_active Application Discontinuation
- 1999-10-21 AR ARP990105310A patent/AR020922A1/es unknown
- 1999-10-22 CO CO99067058A patent/CO5140114A1/es unknown
-
2001
- 2001-04-10 ZA ZA200102970A patent/ZA200102970B/en unknown
- 2001-04-20 NO NO20011966A patent/NO20011966L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1123280A1 (en) | 2001-08-16 |
| SK5372001A3 (en) | 2001-11-06 |
| TW575567B (en) | 2004-02-11 |
| BR9914694A (pt) | 2001-07-10 |
| CN1348444A (zh) | 2002-05-08 |
| AU6341399A (en) | 2000-05-15 |
| AU763667B2 (en) | 2003-07-31 |
| PE20001283A1 (es) | 2000-11-20 |
| KR20010075648A (ko) | 2001-08-09 |
| AR020922A1 (es) | 2002-06-05 |
| WO2000024718A1 (en) | 2000-05-04 |
| US6903107B1 (en) | 2005-06-07 |
| NO20011966L (no) | 2001-04-23 |
| CN1146543C (zh) | 2004-04-21 |
| HUP0103806A3 (en) | 2002-03-28 |
| ID29885A (id) | 2001-10-18 |
| PL347948A1 (en) | 2002-04-22 |
| TR200101120T2 (tr) | 2001-08-21 |
| NO20011966D0 (no) | 2001-04-20 |
| JP2002528438A (ja) | 2002-09-03 |
| ZA200102970B (en) | 2002-07-10 |
| CO5140114A1 (es) | 2002-03-22 |
| RU2232760C2 (ru) | 2004-07-20 |
| NZ511067A (en) | 2003-03-28 |
| CA2346990A1 (en) | 2000-05-04 |
| CZ20011440A3 (cs) | 2001-09-12 |
| IL142398A0 (en) | 2002-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0103806A3 (en) | Serine protease inhibitor and pharmaceutical compositions containing them | |
| HUP0105077A3 (en) | Serine protease inhibitors and pharmaceutical compositions containing them | |
| HUP0104768A3 (en) | 4-amino-3-oxo-azepanes as protease inhibitors and pharmaceutical compositions containing the same | |
| HUP0002942A3 (en) | Peptides having serine protease inhibiting effect pharmaceutical compositions comprising thereof and their use | |
| HUP9900964A3 (en) | Protease inhibitors and pharmaceutical compositions containing these compounds | |
| HUP0300720A3 (en) | Serine protease inhibitors, pharmaceutical compositions containing them and their use | |
| HUP0101699A3 (en) | Benzoxazinones/benzothiazinones as serine protease inhibitors and pharmaceutical compositions containing the same | |
| PL349192A1 (en) | Protease inhibitors | |
| HUP0101484A3 (en) | Quinolones as serine protease inhibitors and medicaments containing them | |
| CY2528B1 (en) | Inhibitors of cysteine protease | |
| AU4236796A (en) | Cysteine protease and serine protease inhibitors | |
| AU7127298A (en) | Serine protease inhibitors | |
| HUP0100669A3 (en) | Peptide derivatives as serine protease inhibitors, their use and pharmaceutical compositions comprising thereof | |
| IL137655A0 (en) | Quinoxalinones as serine protease inhibitors such as factor xa and thrombin | |
| IL120311A0 (en) | Serine protease inhibitors and pharmaceutical compositions containing them | |
| HK1039110A1 (zh) | 以新穎的合成物及組分作為蛋白酶抑制劑 | |
| IL120310A0 (en) | Serine protease inhibitors and pharmaceutical compositions containing them | |
| HUP9901187A3 (en) | Serine protease inhibitors | |
| HUP0002951A3 (en) | Bis-aminomethylcarbonyl compounds as protease inhibitors and pharmaceutical compositions containing them | |
| EP1093367A4 (en) | PROTEASE INHIBITORS | |
| EP0923535A4 (en) | CYSTEINE PROTEASE INHIBITORS | |
| IL139187A0 (en) | Cysteine protease inhibitors | |
| EP1067894A4 (en) | PROTHEASEINHIBITOREN | |
| IL117247A (en) | Pharmaceutical compositions comprising protease inhibitors and quinoxalines | |
| HK1039276A1 (en) | Hydroxamate-containing cysteine and serine protease inhibitors |